Remission and radiographic progression in rheumatoid arthritis.
Complete remission, defined as the presence of clinical as well as radiographic remission, is the ultimate goal of treatment of rheumatoid arthritis (RA). Functional disability in patients with low disease activity is associated with joint inflammation and joint damage. Despite the methodologic problems of scoring radiographs, studies show that radiographic progression is an important outcome measure, and conventional radiography remains the best available method to assess it. Whether radiographic progression is entirely dependent on the presence of joint inflammation is a matter of debate; some evidence suggests that radiologic progression may continue in patients who appear clinically to be in remission. The potential availability of more effective drugs in the near future presents a need to further define and monitor progression of joint damage by more reliable methods. Better diagnosis of joint damage will assist in our quest to attain and document full remission in RA. Some newer techniques that provide direct assessments of metabolic activity in the inflamed joint appear to predict radiographic progression before it can be detected by conventional methods. Until these techniques are validated and assessed for predictive value, we would advocate that radiographic progression be added to existing criteria for clinical remission, in order to define remission in RA more comprehensively.
Voskuyl
A E
AE
VU University Medical Center, Amsterdam, The Netherlands. AE.Voskuyl@vumc.nl
Dijkmans
B A C
BA
D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000628:therapy; D001175:Arthrography; D018450:Disease Progression; D023381:Endpoint Determination; D006801:Humans; D011237:Predictive Value of Tests; D012074:Remission Induction; D012720:Severity of Illness Index